Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $51.3B |
| FY2020, ended Dec 31, 2020 | $94.8B |
| FY2021, ended Dec 31, 2021 | $82.0B |
| FY2022, ended Dec 31, 2022 | $49.7B |
| FY2023, ended Dec 31, 2023 | $128B |
| FY2024, ended Dec 31, 2024 | $126B |
| FY2025, ended Dec 31, 2025 | $168B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $147B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Dec 31, 2017 | $7.93B |
| FY2018, ended Dec 31, 2018 | $10.4B |
| FY2019, ended Dec 31, 2019 | $13.0B |
| FY2020, ended Dec 31, 2020 | $11.1B |
| FY2021, ended Dec 31, 2021 | $17.5B |
| FY2022, ended Dec 31, 2022 | $31.9B |
| FY2023, ended Dec 31, 2023 | $37.3B |
| FY2024, ended Dec 31, 2024 | $44.0B |
| FY2025, ended Dec 31, 2025 | $52.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $55.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Dec 31, 2017 | −$4.03B | −$2.24B |
| FY2018, ended Dec 31, 2018 | $997M | −$2.10B |
| FY2019, ended Dec 31, 2019 | −$8.51B | −$4.91B |
| FY2020, ended Dec 31, 2020 | −$6.77B | −$3.36B |
| FY2021, ended Dec 31, 2021 | −$496M | −$743M |
| FY2022, ended Dec 31, 2022 | −$9.14B | $390M |
| FY2023, ended Dec 31, 2023 | $1.89B | $3.36B |
| FY2024, ended Dec 31, 2024 | $9.86B | $6.89B |
| FY2025, ended Dec 31, 2025 | $10.1B | $9.76B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.58B | $10.1B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Dec 31, 2017 | $4.39B |
| FY2018, ended Dec 31, 2018 | $6.41B |
| FY2019, ended Dec 31, 2019 | $10.9B |
| FY2020, ended Dec 31, 2020 | $5.65B |
| FY2021, ended Dec 31, 2021 | $4.29B |
| FY2022, ended Dec 31, 2022 | $4.21B |
| FY2023, ended Dec 31, 2023 | $4.68B |
| FY2024, ended Dec 31, 2024 | $5.89B |
| FY2025, ended Dec 31, 2025 | $7.11B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.87B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | $6.90B |
| FY2019, ended Dec 31, 2019 | $5.79B |
| FY2020, ended Dec 31, 2020 | $7.91B |
| FY2021, ended Dec 31, 2021 | $9.39B |
| FY2022, ended Dec 31, 2022 | $9.36B |
| FY2023, ended Dec 31, 2023 | $9.56B |
| FY2024, ended Dec 31, 2024 | $9.57B |
| FY2025, ended Dec 31, 2025 | $10.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 379% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Dec 31, 2017 | 426M |
| FY2018, ended Dec 31, 2018 | 1.70B |
| FY2019, ended Dec 31, 2019 | 1.72B |
| FY2020, ended Dec 31, 2020 | 1.86B |
| FY2021, ended Dec 31, 2021 | 1.95B |
| FY2022, ended Dec 31, 2022 | 2.01B |
| FY2023, ended Dec 31, 2023 | 2.08B |
| FY2024, ended Dec 31, 2024 | 2.09B |
| FY2025, ended Dec 31, 2025 | 2.06B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 2.04B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2017, ended Dec 31, 2017 | — | $124M | — |
| FY2018, ended Dec 31, 2018 | — | $170M | — |
| FY2019, ended Dec 31, 2019 | — | $4.60B | — |
| FY2020, ended Dec 31, 2020 | — | $827M | $3.90B |
| FY2021, ended Dec 31, 2021 | — | $1.17B | $929M |
| FY2022, ended Dec 31, 2022 | $0 | $1.79B | — |
| FY2023, ended Dec 31, 2023 | $0 | $1.94B | — |
| FY2024, ended Dec 31, 2024 | $1.25B | $1.80B | — |
| FY2025, ended Dec 31, 2025 | $6.52B | $1.83B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.90B | $1.94B | — |
Valuation
At current price- Market Cap
- $134B
- P/E
- 14.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.4×
- Price / Book
- 4.9×
- EV / EBITDA
- 19.4×
Growth
Trailing 12 months- Revenue (TTM)
- $55.2B
- Revenue Growth YoY
- 16.7%
- Revenue CAGR 3Y
- 17.7%
- Revenue CAGR 5Y
- 36.1%
- EPS Growth YoY
- −22.3%
- Net Income Growth YoY
- −24.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 12.1%
- Net Margin
- 17.3%
- FCF Margin
- 18.3%
- Return on Equity
- 38.4%
Earnings
Trailing 12 months- Net Income
- $9.58B
- EPS (diluted)
- $4.56
- EBITDA
- $7.45B
- Operating Income
- $6.70B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.87B
- Total Debt
- $14.7B
- Net Debt
- $9.85B
- Total Assets
- $65.8B
- Total Liabilities
- $37.4B
- Shareholders' Equity
- $27.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.4B
- Capital Expenditure
- $308M
- Free Cash Flow
- $10.1B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.26
Every ratio is calculated from the company’s reported figures.